Self-reported exercise and bone mineral density in prostate cancer patients receiving androgen deprivation therapy

被引:5
|
作者
Mennen-Winchell, Lori J. [1 ]
Grigoriev, Victor [2 ]
Alpert, Patricia [3 ]
Dos Santos, Hildemar [4 ]
Tonstad, Serena [5 ]
机构
[1] Univ Med Ctr Southern Nevada, Las Vegas, NV 89106 USA
[2] Las Vegas Urol, Las Vegas, NV USA
[3] Univ Nevada, Sch Nursing, Chair Physiol Dept, Las Vegas, NV 89154 USA
[4] Loma Linda Univ, Dept Hlth Promot & Educ, Loma Linda, CA 92350 USA
[5] Loma Linda Univ, Dept Hlth Promot & Educ, Loma Linda, CA 92350 USA
关键词
Androgen ablation therapy; cancer; bone mineral density; exercise; PHYSICAL-ACTIVITY; AMERICAN-COLLEGE; MEN; OSTEOPOROSIS; MANAGEMENT;
D O I
10.1002/2327-6924.12066
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: Men with prostate cancer receiving androgen deprivation therapy (ADT) are at increased risk for decreased bone mineral density (BMD). This study evaluates the relationship between self-reported daily activity, endurance and resistance exercise, and BMD measured by dual-energy x-ray absorptiometry (DEXA) in prostate cancer patients receiving ADT. Data sources: We recruited 96 men treated with ADT for >= 9 months from urology and cancer practices. The Canadian Fitness Survey assessed daily activity and exercise. Data on demographic and lifestyle characteristics and calcium and vitamin D supplementation were collected. Blood was collected for analysis of 25-OH vitamin D. A DEXA scan was performed. Conclusions: A positive association between endurance exercise and DEXA T-scores of the hip was shown. Regression analysis showed endurance exercise of medium to heavy intensity (measured as energy expenditure in METhours/week) was associated with T-scores of the hip (beta = 0.048; 95% CI 0.003, 0.112; p =.040) but not with spinal T-scores after controlling for age, body mass index, and alcohol use. Implications for practice: Findings are cross-sectional, but if confirmed in prospective studies suggest that increased endurance exercise is a practical measure nurse practitioners can institute to prevent low bone density in the hip of men treated with ADT.
引用
收藏
页码:40 / 48
页数:9
相关论文
共 50 条
  • [1] Effect of androgen deprivation therapy on bone mineral density in prostate cancer patients
    Deng, JH
    Yang, LP
    Wang, LS
    Zhou, DF
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2004, 6 (01) : 75 - 77
  • [2] Effect of androgen deprivation therapy on bone mineral density in patients with prostate cancer
    Ilyas, Kashaf
    Hafeez, Zainab
    Latif, Rukhsana
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (05) : 1175 - 1182
  • [4] CAP STUDY: SELF REPORTED EXERCISE AND RISK OF OSTEOPOROSIS IN PROSTATE CANCER PATIENTS RECEIVING ANDROGEN DEPRIVATION THERAPY
    Winchell, Lori J.
    Tonstad, Serena
    Grigoriev, Victor
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S433 - S433
  • [5] Effect of Diphosphonates on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
    Wu, Congcong
    Chen, Wenjun
    Huang, Xuanzhang
    Lin, Ruifang
    Wu, Jian
    Zhang, Xi
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (06) : E1243 - E1250
  • [6] Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
    Smith, Matthew R.
    Saad, Fred
    Egerdie, Blair
    Szwedowski, Maciej
    Tammela, Teuvo L. J.
    Ke, Chunlei
    Leder, Benjamin Z.
    Goessl, Carsten
    [J]. JOURNAL OF UROLOGY, 2009, 182 (06): : 2670 - 2675
  • [7] Androgen deprivation therapy in patients with prostate cancer and changes in bone mineral density.
    Alferos, MG
    Yaturu, S
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S243 - S243
  • [8] Changes in bone mineral density in patients with prostate cancer treated with androgen deprivation therapy
    Bernat, MM
    Pasini, J
    Marekovic, Z
    [J]. COLLEGIUM ANTROPOLOGICUM, 2005, 29 (02) : 589 - 591
  • [9] Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancer
    Morgans, A. K.
    Hancock, M. L.
    Barnette, G.
    Steiner, M. S.
    Morton, R. A.
    Smith, M. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [10] Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer COMMENT
    Singer, Frederick R.
    [J]. JOURNAL OF UROLOGY, 2009, 182 (06): : 2676 - 2676